Description
This product utilizes regulatory B cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone I1C1R122-4). We employs the Lentivirus (SV40-Cy2-TFIIB-SpeI) vector components and the SynExpress system of the exons Insertion/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
I1C1R122-4
Species Reactivity
Human
Cell Source
Regulatory B cells
Sensor Gene
Cy2
Promoter
SV40
Effector Gene
TFIIB
Insertion Sites
SpeI
Gene Modification
Insertion
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.96
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.